AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Merchants Bancorp, you have to be comfortable backing a relatively small, diversified lender that screens as inexpensive on earnings and cash flow estimates, yet carries some credit and execution questions. The upcoming earnings, with the market braced for only modest revenue growth and another potential revenue miss versus Street expectations, put short term focus squarely on whether management can regain forecasting credibility and show that recent margin and profit pressure is stabilizing. Index additions to the S&P 600 and several Russell growth benchmarks have already increased the stock’s visibility and likely attracted more institutional capital, but the recent share price drift suggests the market is waiting for clearer proof that earnings growth forecasts are realistic. At the same time, elevated bad loans and a relatively low allowance remain key risks if conditions worsen.
However, one risk around credit quality and loss reserves is easy to overlook until it matters. Despite retreating, Merchants Bancorp's shares might still be trading above their fair value and there could be some more downside. Discover how much.Explore another fair value estimate on Merchants Bancorp - why the stock might be worth just $53.50!
Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Opportunities like this don't last. These are today's most promising picks. Check them out now:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com